People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

The FDA has approved the use of Spravato, an antidepressant nasal spray, as a standalone treatment for depression in the U.S. Sue Varma discusses why she supports the use of the drug and how it may ...

CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

President Trump’s nominee to head the Department of Health and Human Services, Robert Kennedy Jr., will soon go before the ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

Analyst Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on Milestone Pharmaceuticals (MIST – Research Report) and keeping the ...

An ear, nose and throat doctor explains why tipping your head back with a nosebleed could make things worse and what you ...

Nasal steroids provided the most significant benefit, especially when compared to montelukast. Nasal antihistamines also ...

Doctors shared their must-have sick season buys with The Post, revealing which medicines, supplements and tools you should ...

Researchers delivered a dose of the “love hormone” oxytocin via a nasal spray to participants and found that it decreased ...

Here are the top health headlines for the week of Jan. 19, 2025. A nasal spray derived from ketamine gets federal clearance ...